Drugs / TMP001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02686788 | Aug 2015 → Apr 2018 | relapsing-remitting multiple sclerosis | Dr. Frank Behrens | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMP001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02686788 ↗ |
| Route | Oral | “taken orally” NCT02686788 ↗ |